MS Research: Study shows promise in repairing damaged myelin
https://news.ohsu.edu/2019/04/18/study-shows-promise-in-repairing-damaged-myelin
"Study shows promise in repairing damaged myelin
OHSU researchers collaborate on potential game-changer for people with multiple sclerosis.
Researchers found that the treatment in mice not only triggered myelin repair, but they also measured substantial motor improvements in mice treated with the compound.
The mouse showed close to a full recovery, Scanlan said.
Scientists say they are confident that the compound will translate from mice to people. To that end, OHSU has licensed the technology to Llama Therapeutics Inc., a biotechnology company in San Carlos, California. Llama is working to advance these molecules toward human clinical trials in MS and other diseases.
Bourdette said even though it may not help his patients today, hes optimistic the discovery eventually will move from the lab into the clinic.
Right now, what it means is hope, he said."